Lead programme: SARS-CoV-1/SARS-CoV-2 Coronavirus vaccine and Dengue Fever vaccine
Our next-generation T-Cell Adaptive Vaccine candidates have the potential to tackle major global diseases and can offer efficacy against a range of viral pathogens including Dengue, Coronavirus, Influenza, Zika, Yellow fever, as well as intracellular bacteria.